These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23457458)

  • 1. Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.
    Nakaso K; Tajima N; Ito S; Teraoka M; Yamashita A; Horikoshi Y; Kikuchi D; Mochida S; Nakashima K; Matsura T
    PLoS One; 2013; 8(2):e55068. PubMed ID: 23457458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 Cells.
    Khalife M; Morshedi D; Aliakbari F; Tayaranian Marvian A; Mohammad Beigi H; Azimzadeh Jamalkandi S; Pan-Montojo F
    Protein J; 2015 Aug; 34(4):291-303. PubMed ID: 26250981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability.
    Wang C; Liu L; Zhang L; Peng Y; Zhou F
    Biochemistry; 2010 Sep; 49(37):8134-42. PubMed ID: 20701279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of large oligomers of DOPAL-modified α-synuclein is modulated by the oxidation of methionine residues located at C-terminal domain.
    Coelho-Cerqueira E; de Araújo Correia Campos C; Follmer C
    Biochem Biophys Res Commun; 2019 Feb; 509(2):367-372. PubMed ID: 30591215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions.
    Zhou W; Long C; Reaney SH; Di Monte DA; Fink AL; Uversky VN
    Biochim Biophys Acta; 2010 Mar; 1802(3):322-30. PubMed ID: 20026206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease.
    Gorbatyuk OS; Li S; Sullivan LF; Chen W; Kondrikova G; Manfredsson FP; Mandel RJ; Muzyczka N
    Proc Natl Acad Sci U S A; 2008 Jan; 105(2):763-8. PubMed ID: 18178617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an Alternatively Spliced α-Synuclein Isoform That Generates a 41-Amino Acid N-Terminal Truncated Peptide, 41-syn: Role in Dopamine Homeostasis.
    Vinnakota RL; Yedlapudi D; Manda KM; Bhamidipati K; Bommakanti KT; RangaLakshmi GS; Kalivendi SV
    ACS Chem Neurosci; 2018 Dec; 9(12):2948-2958. PubMed ID: 29996045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.
    Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH
    ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations.
    Norris EH; Giasson BI; Hodara R; Xu S; Trojanowski JQ; Ischiropoulos H; Lee VM
    J Biol Chem; 2005 Jun; 280(22):21212-9. PubMed ID: 15817478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure.
    Ponzini E; De Palma A; Cerboni L; Natalello A; Rossi R; Moons R; Konijnenberg A; Narkiewicz J; Legname G; Sobott F; Mauri P; Santambrogio C; Grandori R
    J Biol Chem; 2019 Apr; 294(14):5657-5665. PubMed ID: 30755483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.
    Xu S; Chan P
    Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular oligomerization of alpha-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence.
    Mazzulli JR; Armakola M; Dumoulin M; Parastatidis I; Ischiropoulos H
    J Biol Chem; 2007 Oct; 282(43):31621-30. PubMed ID: 17785456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease.
    McFarland NR; Fan Z; Xu K; Schwarzschild MA; Feany MB; Hyman BT; McLean PJ
    J Neuropathol Exp Neurol; 2009 May; 68(5):515-24. PubMed ID: 19525899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
    Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.
    Lewis KA; Yaeger A; DeMartino GN; Thomas PJ
    J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotective effect of chlorogenic acid against α-synuclein-related toxicity in catecholaminergic PC12 cells.
    Teraoka M; Nakaso K; Kusumoto C; Katano S; Tajima N; Yamashita A; Zushi T; Ito S; Matsura T
    J Clin Biochem Nutr; 2012 Sep; 51(2):122-7. PubMed ID: 22962530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of alpha-synuclein aggregation by dopamine: a review.
    Leong SL; Cappai R; Barnham KJ; Pham CL
    Neurochem Res; 2009 Oct; 34(10):1838-46. PubMed ID: 19444607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.